<<(I don't rate a new manager a relevant news).>>
Well I certainly do.
Ph.D. from MIT, "15 years of successful experience in bringing chemical processes to market", "previously headed the Plastics Manufacturing company of Borden Chemical,
"founder and CEO of Med-Genesis, Inc", "awarded 15 U.S. patents."
Ask yourself, why would a man with this type of credentials come to little ENBC and take the top operating position at this time?
The very fact that Nasser wanted to fill that position and that Dr. Policastro took the position, is significant. If he wasn't sure himself, a couple of calls to MIT cohorts would confirm or show up ENBC's prospects.
He took the job, which is extremely bullish for ENBC, IMO - and I bet there are institutions out there that will agree with me.
Post-split the total float is less than 2 million shares. If the Yahoo! thread is correct and the liquid float is only 250K shares, then this stock could soar on any good news. Having bought a lot recently at $2 (at that price it was a decision of a potential 10-bagger vs a possible loss of under $10K and I just have a feeling that things are getting better), I now hold over 2% of that 250K, and I'm not selling. Add others on these threads and the liquid float is perhaps much less than that.
If the price holds above $5, other institutions may not be prohibited from buying, as was the case before.
Let's see, a $2 million contract equates to $1 EPS, and that is tiny as contracts might go. What would a larger (or multiple) contract do to the stock price with this low liquid float? I'm holding to find out. |
